[HTML][HTML] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

H Feng, B Li, Z Li, Q Wei, L Ren - BMC cancer, 2021 - Springer
Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
of the digestive system and has high morbidity and mortality rates. It is essential to search …

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.

H Feng, B Li, Z Li, Q Wei, L Ren - BMC Cancer, 2021 - europepmc.org
Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
of the digestive system and has high morbidity and mortality rates. It is essential to search …

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

H Feng, B Li, Z Li, Q Wei, L Ren - BMC cancer, 2021 - pubmed.ncbi.nlm.nih.gov
Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
of the digestive system and has high morbidity and mortality rates. It is essential to search …

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

H Feng, L Bole, Z Li, W Qian, R Li - BMC Cancer, 2021 - search.proquest.com
Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
of the digestive system and has high morbidity and mortality rates. It is essential to search …

[HTML][HTML] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

H Feng, B Li, Z Li, Q Wei, L Ren - BMC Cancer, 2021 - ncbi.nlm.nih.gov
Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
of the digestive system and has high morbidity and mortality rates. It is essential to search …

[PDF][PDF] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

H Feng, B Li, Z Li, Q Wei, L Ren - 2021 - scholar.archive.org
Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
of the digestive system and has high morbidity and mortality rates. It is essential to search …

[HTML][HTML] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

H Feng, B Li, Z Li, Q Wei, L Ren - BMC Cancer, 2021 - bmccancer.biomedcentral.com
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the
digestive system and has high morbidity and mortality rates. It is essential to search new …

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.

H Feng, B Li, Z Li, Q Wei, L Ren - BMC Cancer, 2021 - search.ebscohost.com
Abstract < bold> Background: </bold> Hepatocellular carcinoma (HCC) is one of
the most common malignant tumors of the digestive system and has high morbidity and …

[PDF][PDF] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

H Feng, B Li, Z Li, Q Wei, L Ren - 2021 - bmccancer.biomedcentral.com
Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
of the digestive system and has high morbidity and mortality rates. It is essential to search …